On March 31, the official website of NMPA showed that Nanjing Tefeng Pharmaceutical Co.
2 new drug chloral hydrate/syrup combination packaging was officially approved.
It is reported that the drug is one of the first varieties to encourage research and development to declare children's drugs.
Chloral hydrate was discovered in 1832.
In 1872, Dr.
Pierre first reported its application to human intravenous anesthesia.
However, it was questioned due to the high mortality of anesthesia and the slow recovery of patients.
Later, it was mainly used for animal anesthesia.
Chloral hydrate is currently one of the commonly used drugs for pediatric sedation.
In China, chloral hydrate oral solution, oral suspension or enema is included in the "List of the First Batch of Children's Drugs to Encourage Research and Development.
" In December 2019, Tefeng Pharmaceutical's chloral hydrate enema was approved by NMPA for sedation, becoming the first domestic marketed preparation of chloral hydrate for children.